Perceptive Advisors LLC, Director at Cerevel Therapeutics Holdings, Inc. (CERE), bought 351,170 shares at $25.78 ($9.7M) on 2021-08-23, disclosed to the SEC on 2021-08-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.78 | 44,437 | $1.1M | 11.8% |
| 2 | $25.78 | 44,437 | $1.1M | 11.8% |
| 3 | $27.73 | 69,761 | $1.9M | 20.0% |
| 4 | $27.73 | 69,761 | $1.9M | 20.0% |
| 5 | $28.57 | 61,387 | $1.8M | 18.1% |
| 6 | $28.57 | 61,387 |
| $1.8M |
| 18.1% |
| Total | $27.53 avg | 351,170 | $9.7M | 100% |
| Filing → |
| ACRV | SELL | 2025-05-01 | $2.0M | — | Filing → |
| ACRV | SELL | 2025-04-29 | $5.1M | — | Filing → |
| VRCA | BUY | 2023-12-26 | $3.6M | — | Filing → |